{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T22:50:52Z","timestamp":1785624652364,"version":"3.56.0"},"publisher-location":"New York, NY","reference-count":57,"publisher":"Springer US","isbn-type":[{"value":"9781071651650","type":"print"},{"value":"9781071651667","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5166-7_2","type":"book-chapter","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T22:08:19Z","timestamp":1785622099000},"page":"23-38","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-Translational Modifications in Protein Therapeutics: Importance and Analytical Tools"],"prefix":"10.1007","author":[{"given":"Emily E. F.","family":"Fekete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"1","key":"2_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrd2399","volume":"7","author":"B Leader","year":"2008","unstructured":"Leader B, Baca QJ, Golan DE (2008) Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov 7(1):21\u201339","journal-title":"Nat Rev Drug Discov"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3389\/fendo.2018.00613","volume":"9","author":"I Vecchio","year":"2018","unstructured":"Vecchio I, Tornali C, Bragazzi NL, Martini M (2018) The discovery of insulin: an important milestone in the history of medicine. Front Endocrinol (Lausanne) 9:613","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2337\/diaspect.27.2.82","volume":"27","author":"Jr. JR White","year":"2014","unstructured":"White Jr. JR (2014) A brief history of the development of diabetes medications. Diabetes Spectr 27(2):82\u201386","journal-title":"Diabetes Spectr"},{"issue":"10","key":"2_CR4","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/nbt1252","volume":"24","author":"G Walsh","year":"2006","unstructured":"Walsh G, Jefferis R (2006) Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 24(10):1241\u20131252","journal-title":"Nat Biotechnol"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/srep00090","volume":"1","author":"GA Khoury","year":"2011","unstructured":"Khoury GA, Baliban RC, Floudas CA (2011) Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database. Sci Rep 1:90","journal-title":"Sci Rep"},{"issue":"10","key":"2_CR6","doi-asserted-by":"publisher","first-page":"BSR20220094","DOI":"10.1042\/BSR20220094","volume":"42","author":"N Thompson","year":"2022","unstructured":"Thompson N, Wakarchuk W (2022) O-glycosylation and its role in therapeutic proteins. Biosci Rep 42(10):BSR20220094","journal-title":"Biosci Rep"},{"issue":"24","key":"2_CR7","doi-asserted-by":"publisher","first-page":"8859","DOI":"10.3390\/molecules27248859","volume":"27","author":"B Chen","year":"2022","unstructured":"Chen B, Liu W, Li Y, Ma B, Shang S, Tan Z (2022) Impact of N-linked glycosylation on therapeutic proteins. Molecules 27(24):8859","journal-title":"Molecules"},{"key":"2_CR8","doi-asserted-by":"crossref","unstructured":"Kohler J, Patrie SM (ed) (2013) Mass spectrometry of glycoproteins: methods and protocols. In: Methods in molecular biology, vol 951. Springer, Heidelberg","DOI":"10.1007\/978-1-62703-146-2"},{"issue":"1","key":"2_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92225-9","volume":"11","author":"H Nakamura","year":"2021","unstructured":"Nakamura H, Yoshikawa M, Oda-Ueda N, Ueda T, Ohkuri T (2021) A comprehensive analysis of novel disulfide bond introduction site into the constant domain of human Fab. Sci Rep 11(1):12937","journal-title":"Sci Rep"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-1241-5_1","volume":"2271","author":"A Delobel","year":"2021","unstructured":"Delobel A (2021) Glycosylation of therapeutic proteins: a critical quality attribute. Methods Mol Biol 2271:1\u201321","journal-title":"Methods Mol Biol"},{"issue":"4","key":"2_CR11","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00216-021-03756-z","volume":"414","author":"P Bults","year":"2022","unstructured":"Bults P, van der Voort A, Meijer C, Sonke GS, Bischoff R, van de Merbel NC (2022) Analytical and pharmacological consequences of the in vivo deamidation of trastuzumab and pertuzumab. Anal Bioanal Chem 414(4):1513\u20131524","journal-title":"Anal Bioanal Chem"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.47577\/biochemmed.v13i.12527","volume":"13","author":"K Taraj","year":"2025","unstructured":"Taraj K (2025) Review on characterization of deamidation in therapeutic proteins by mass spectrometric methods. Technium BioChemMed 13:13\u201326","journal-title":"Technium BioChemMed"},{"issue":"2","key":"2_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4161\/mabs.27876","volume":"6","author":"M Haberger","year":"2014","unstructured":"Haberger M, Bomans K, Diepold K, Hook M, Gassner J, Schlothauer T, Zwick A, Spick C, Kepert JF, Hienz B, Wiedmann M, Beck H, Metzger P, Molhoj M, Knoblich C, Grauschopf U, Reusch D, Bulau P (2014) Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: susceptibility vs. functionality of critical quality attributes. Mabs 6(2):327\u2013339","journal-title":"Mabs"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.omtm.2019.09.008","volume":"15","author":"JA Delmar","year":"2019","unstructured":"Delmar JA, Wang J, Choi SW, Martins JA, Mikhail JP (2019) Machine learning enables accurate prediction of asparagine deamidation probability and rate. Mol Ther Methods Clin Dev 15:264\u2013274","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"2_CR15","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1039\/D1CB00067E","volume":"2","author":"MLE Lundahl","year":"2021","unstructured":"Lundahl MLE, Fogli S, Colavita PE, Scanlan EM (2021) Aggregation of protein therapeutics enhances their immunogenicity: causes and mitigation strategies. RSC Chem Biol 2(4):1004\u20131020","journal-title":"RSC Chem Biol"},{"issue":"3","key":"2_CR16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/btpr.1548","volume":"28","author":"A Eon-Duval","year":"2012","unstructured":"Eon-Duval A, Broly H, Gleixner R (2012) Quality attributes of recombinant therapeutic proteins: an assessment of impact on safety and efficacy as part of a quality by design development approach. Biotechnol Prog 28(3):608\u2013622","journal-title":"Biotechnol Prog"},{"issue":"8","key":"2_CR17","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1002\/jps.22097","volume":"99","author":"SK Singh","year":"2010","unstructured":"Singh SK, Afonina N, Awwad M, Bechtold-Peters K, Blue JT, Chou D, Cromwell M, Krause HJ, Mahler HC, Meyer BK, Narhi L, Nesta DP, Spitznagel T (2010) An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. J Pharm Sci 99(8):3302\u20133321","journal-title":"J Pharm Sci"},{"issue":"3","key":"2_CR18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11095-013-1199-9","volume":"31","author":"R Torosantucci","year":"2014","unstructured":"Torosantucci R, Schoneich C, Jiskoot W (2014) Oxidation of therapeutic proteins and peptides: structural and biological consequences. Pharm Res 31(3):541\u2013553","journal-title":"Pharm Res"},{"issue":"1","key":"2_CR19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.xphs.2019.10.051","volume":"109","author":"ME Alam","year":"2020","unstructured":"Alam ME, Slaney TR, Wu L, Das TK, Kar S, Barnett GV, Leone A, Tessier PM (2020) Unique impacts of methionine oxidation, tryptophan oxidation, and asparagine deamidation on antibody stability and aggregation. J Pharm Sci 109(1):656\u2013669","journal-title":"J Pharm Sci"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"862456","DOI":"10.3389\/fbioe.2022.862456","volume":"10","author":"J Coghlan","year":"2022","unstructured":"Coghlan J, Benet A, Kumaran P, Ford M, Veale L, Skilton SJ, Saveliev S, Schwendeman AA (2022) Streamlining the characterization of disulfide bond shuffling and protein degradation in IgG1 biopharmaceuticals under native and stressed conditions. Front Bioeng Biotechnol 10:862456","journal-title":"Front Bioeng Biotechnol"},{"issue":"3","key":"2_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1021\/acsbiomedchemau.1c00054","volume":"2","author":"A Das","year":"2022","unstructured":"Das A, Shah M, Saraogi I (2022) Molecular aspects of insulin aggregation and various therapeutic interventions. ACS Bio Med Chem Au 2(3):205\u2013221","journal-title":"ACS Bio Med Chem Au"},{"issue":"6","key":"2_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0141-0229(94)90014-0","volume":"16","author":"DJ Merkler","year":"1994","unstructured":"Merkler DJ (1994) C-terminal amidated peptides: production by the in vitro enzymatic amidation of glycine-extended peptides and the importance of the amide to bioactivity. Enzyme Microb Technol 16(6):450\u2013456","journal-title":"Enzyme Microb Technol"},{"issue":"7","key":"2_CR23","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1080\/19420862.2019.1631116","volume":"11","author":"CA Xu","year":"2019","unstructured":"Xu CA, Feng AZ, Ramineni CK, Wallace MR, Culyba EK, Guay KP, Mehta K, Mabry R, Farrand S, Xu J, Feng J (2019) L(445)P mutation on heavy chain stabilizes IgG(4) under acidic conditions. Mabs 11(7):1289\u20131299","journal-title":"Mabs"},{"issue":"1","key":"2_CR24","doi-asserted-by":"publisher","first-page":"2259289","DOI":"10.1080\/19420862.2023.2259289","volume":"15","author":"CB Lietz","year":"2023","unstructured":"Lietz CB, Deyanova E, Cho Y, Cordia J, Franc S, Kabro S, Wang S, Mikolon D, Banks DD (2023) Identification of tyrosine sulfation in the variable region of a bispecific antibody and its effect on stability and biological activity. Mabs 15(1):2259289","journal-title":"Mabs"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"123981","DOI":"10.1016\/j.jchromb.2023.123981","volume":"1233","author":"H Luo","year":"2024","unstructured":"Luo H, Mahon D, Wong P, Madayiputhiya N, Chen Y, Stauffer T, Tao L, Zeng M (2024) Structure-function relationship study for sulfated protein therapeutics using hydrophobic interaction chromatography and mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 1233:123981","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"2_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.thromres.2012.09.011","volume":"131","author":"C Kannicht","year":"2013","unstructured":"Kannicht C, Ramstrom M, Kohla G, Tiemeyer M, Casademunt E, Walter O, Sandberg H (2013) Characterisation of the post-translational modifications of a novel, human cell line-derived recombinant human factor VIII. Thromb Res 131(1):78\u201388","journal-title":"Thromb Res"},{"issue":"1","key":"2_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19488-8","volume":"12","author":"YM She","year":"2022","unstructured":"She YM, Dai S, Tam RY (2022) Highly sensitive characterization of non-human glycan structures of monoclonal antibody drugs utilizing tandem mass spectrometry. Sci Rep 12(1):15109","journal-title":"Sci Rep"},{"issue":"1","key":"2_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41392-022-01245-y","volume":"7","author":"S Shang","year":"2022","unstructured":"Shang S, Liu J, Hua F (2022) Protein acylation: mechanisms, biological functions and therapeutic targets. Signal Transduct Target Ther 7(1):396","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2_CR29","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1002\/mco2.261","volume":"4","author":"Q Zhong","year":"2023","unstructured":"Zhong Q, Xiao X, Qiu Y, Xu Z, Chen C, Chong B, Zhao X, Hai S, Li S, An Z, Dai L (2023) Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications. MedComm (2020) 4(3):e261","journal-title":"MedComm (2020)"},{"issue":"2","key":"2_CR30","doi-asserted-by":"publisher","first-page":"001136","DOI":"10.1099\/mic.0.001136","volume":"168","author":"EVK Ledger","year":"2022","unstructured":"Ledger EVK, Sabnis A, Edwards AM (2022) Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort. Microbiology 168(2):001136","journal-title":"Microbiology"},{"issue":"22","key":"2_CR31","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1002\/cmdc.201600374","volume":"11","author":"SB van Witteloostuijn","year":"2016","unstructured":"van Witteloostuijn SB, Pedersen SL, Jensen KJ (2016) Half-life extension of biopharmaceuticals using chemical methods: alternatives to PEGylation. ChemMedChem 11(22):2474\u20132495","journal-title":"ChemMedChem"},{"issue":"10","key":"2_CR32","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.amjmed.2014.07.005","volume":"127","author":"JM Tibaldi","year":"2014","unstructured":"Tibaldi JM (2014) Evolution of insulin: from human to analog. Am J Med 127(10):S25\u201338","journal-title":"Am J Med"},{"issue":"6","key":"2_CR33","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.drudis.2022.03.011","volume":"27","author":"C Bleuez","year":"2022","unstructured":"Bleuez C, Koch WF, Urbach C, Hollfelder F, Jermutus L (2022) Exploiting protease activation for therapy. Drug Discov Today 27(6):1743\u20131754","journal-title":"Drug Discov Today"},{"issue":"10","key":"2_CR34","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1111\/febs.15227","volume":"287","author":"M Poreba","year":"2020","unstructured":"Poreba M (2020) Protease-activated prodrugs: strategies, challenges, and future directions. FEBS J 287(10):1936\u20131969","journal-title":"FEBS J"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"114904","DOI":"10.1016\/j.addr.2023.114904","volume":"199","author":"M Shi","year":"2023","unstructured":"Shi M, McHugh KJ (2023) Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems. Adv Drug Deliv Rev 199:114904","journal-title":"Adv Drug Deliv Rev"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jpba.2018.03.034","volume":"154","author":"S Wang","year":"2018","unstructured":"Wang S, Liu AP, Yan Y, Daly TJ, Li N (2018) Characterization of product-related low molecular weight impurities in therapeutic monoclonal antibodies using hydrophilic interaction chromatography coupled with mass spectrometry. J Pharm Biomed Anal 154:468\u2013475","journal-title":"J Pharm Biomed Anal"},{"key":"2_CR37","unstructured":"ICH (1995) Quality of biotechnological products: stability testing of biotechnological\/biological products [Q5C]. In: ICH Quality Guidelines. https:\/\/www.ich.org\/page\/quality-guidelines. Accessed 01 May, 2025"},{"key":"2_CR38","unstructured":"ICH (1995) Specifications: test procedures and acceptance criteria for biotechnological\/biological products [Q5B]. In: ICH Quality Guidelines. https:\/\/www.ich.org\/page\/quality-guidelines. Accessed 01 May, 2025"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"116301","DOI":"10.1016\/j.jpba.2024.116301","volume":"248","author":"R Cageling","year":"2024","unstructured":"Cageling R, Carillo S, Boumeester AJ, Lubbers-Geuijen K, Bones J, Jooss K, Somsen GW (2024) Microfluidic capillary electrophoresis \u2013 mass spectrometry for rapid charge-variant and glycoform assessment of monoclonal antibody biosimilar candidates. J Pharm Biomed Anal 248:116301","journal-title":"J Pharm Biomed Anal"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"116386","DOI":"10.1016\/j.jpba.2024.116386","volume":"249","author":"T Cernosek","year":"2024","unstructured":"Cernosek T, Dalphin M, Sakowski J, Behrens S, Wunderli P (2024) Application of analytical quality by design to the development and validation of reduced and non-reduced capillary electrophoresis analytical procedures for mAb purity determination. J Pharm Biomed Anal 249:116386","journal-title":"J Pharm Biomed Anal"},{"issue":"8","key":"2_CR41","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1021\/jasms.0c00446","volume":"32","author":"M Haberger","year":"2021","unstructured":"Haberger M, Heidenreich AK, Hook M, Fichtl J, Lang R, Cymer F, Adibzadeh M, Kuhne F, Wegele H, Reusch D, Bonnington L, Bulau P (2021) Multiattribute monitoring of antibody charge variants by cation-exchange chromatography coupled to native mass spectrometry. J Am Soc Mass Spectrom 32(8):2062\u20132071","journal-title":"J Am Soc Mass Spectrom"},{"issue":"3","key":"2_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1208\/s12249-025-03076-w","volume":"26","author":"C Winter","year":"2025","unstructured":"Winter C, Springer A, Descamps JL, Hoefinghoff J, Mohammad-Sadegh S, Paudel A, Stankovic-Brandl M (2025) Unraveling the effects of filtration, process interruptions, and post-process agitation on protein aggregation. AAPS PharmSciTech 26(3):85","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"2_CR43","doi-asserted-by":"publisher","first-page":"2133674","DOI":"10.1080\/19420862.2022.2133674","volume":"14","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Yan Y, Wang S, Li N (2022) A competitive binding-mass spectrometry strategy for high-throughput evaluation of potential critical quality attributes of therapeutic monoclonal antibodies. Mabs 14(1):2133674","journal-title":"Mabs"},{"key":"2_CR44","doi-asserted-by":"publisher","first-page":"124205","DOI":"10.1016\/j.jchromb.2024.124205","volume":"1242","author":"T Cernosek","year":"2024","unstructured":"Cernosek T, Dalphin M, Jain N, Lor J, Richter N, Mellal M, Behrens S, Wunderli P (2024) A case study application of AQbD to the re-development and validation of an affinity chromatography analytical procedure for mAb titer quantitation. J Chromatogr B Analyt Technol Biomed Life Sci 1242:124205","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"972168","DOI":"10.3389\/fimmu.2022.972168","volume":"13","author":"G Hatfield","year":"2022","unstructured":"Hatfield G, Tepliakova L, Gingras G, Stalker A, Li X, Aubin Y, Tam RY (2022) Specific location of galactosylation in an afucosylated antiviral monoclonal antibody affects its Fc\u03b3RIIIA binding affinity. Front Immunol 13:972168","journal-title":"Front Immunol"},{"issue":"23","key":"2_CR46","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1002\/(SICI)1097-0231(19981215)12:23<1867::AID-RCM407>3.0.CO;2-S","volume":"12","author":"J Fernandez-de-Cossio","year":"1998","unstructured":"Fernandez-de-Cossio J, Gonzalez J, Betancourt L, Besada V, Padron G, Shimonishi Y, Takao T (1998) Automated interpretation of high-energy collision-induced dissociation spectra of singly protonated peptides by \u2018SeqMS\u2019, a software aid for de novo sequencing by tandem mass spectrometry. Rapid Commun Mass Spectrom 12(23):1867\u20131878","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"3","key":"2_CR47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nmeth1019","volume":"4","author":"JE Elias","year":"2007","unstructured":"Elias JE, Gygi SP (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 4(3):207\u2013214","journal-title":"Nat Methods"},{"issue":"9","key":"2_CR48","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M (2014) Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13(9):2513\u20132526","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"2_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/proteomes9010015","volume":"9","author":"BC Orsburn","year":"2021","unstructured":"Orsburn BC (2021) Proteome discoverer-a community enhanced data processing suite for protein informatics. Proteomes 9(1):15","journal-title":"Proteomes"},{"issue":"12","key":"2_CR50","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Cox J (2016) The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc 11(12):2301\u20132319","journal-title":"Nat Protoc"},{"issue":"6","key":"2_CR51","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1021\/pr800982s","volume":"8","author":"M Brosch","year":"2009","unstructured":"Brosch M, Yu L, Hubbard T, Choudhary J (2009) Accurate and sensitive peptide identification with Mascot Percolator. J Proteome Res 8(6):3176\u20133181","journal-title":"J Proteome Res"},{"issue":"22","key":"2_CR52","doi-asserted-by":"publisher","first-page":"14170","DOI":"10.1021\/acs.analchem.9b03808","volume":"91","author":"S Rogstad","year":"2019","unstructured":"Rogstad S, Yan H, Wang X, Powers D, Brorson K, Damdinsuren B, Lee S (2019) Multi-attribute method for quality control of therapeutic proteins. Anal Chem 91(22):14170\u201314177","journal-title":"Anal Chem"},{"issue":"5","key":"2_CR53","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/19420862.2015.1069454","volume":"7","author":"RS Rogers","year":"2015","unstructured":"Rogers RS, Nightlinger NS, Livingston B, Campbell P, Bailey R, Balland A (2015) Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics. Mabs 7(5):881\u2013890","journal-title":"Mabs"},{"issue":"1","key":"2_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2197668","volume":"15","author":"F Yang","year":"2023","unstructured":"Yang F, Zhang J, Buettner A, Vosika E, Sadek M, Hao Z, Reusch D, Koenig M, Chan W, Bathke A, Pallat H, Lundin V, Kepert JF, Bulau P, Deperalta G, Yu C, Beardsley R, Camilli T, Harris R, Stults J (2023) Mass spectrometry-based multi-attribute method in protein therapeutics product quality monitoring and quality control. Mabs 15(1):2197668","journal-title":"Mabs"},{"issue":"8","key":"2_CR55","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1080\/10408347.2023.2238058","volume":"54","author":"S Millan-Martin","year":"2024","unstructured":"Millan-Martin S, Jakes C, Carillo S, Gallagher L, Scheffler K, Broster K, Bones J (2024) Multi-attribute method (MAM): an emerging analytical workflow for biopharmaceutical characterization, batch release and cGMP purity testing at the peptide and intact protein level. Crit Rev Anal Chem 54(8):3234\u20133251","journal-title":"Crit Rev Anal Chem"},{"key":"2_CR56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejpb.2022.07.005","volume":"177","author":"S Carillo","year":"2022","unstructured":"Carillo S, Criscuolo A, Fussl F, Cook K, Bones J (2022) Intact multi-attribute method (iMAM): a flexible tool for the analysis of monoclonal antibodies. Eur J Pharm Biopharm 177:241\u2013248","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"2_CR57","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/ph16020291","volume":"16","author":"HA Alhazmi","year":"2023","unstructured":"Alhazmi HA, Albratty M (2023) Analytical techniques for the characterization and quantification of monoclonal antibodies. Pharmaceuticals (Basel) 16(2):291","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Methods in Molecular Biology","Protein Post-Translational Modifications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5166-7_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T22:08:20Z","timestamp":1785622100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5166-7_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071651650","9781071651667"],"references-count":57,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5166-7_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}